Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gold Bond is a well-established brand of over-the-counter (OTC) topical medicated products, primarily known for its body powders and creams. The flagship formulation, Gold Bond Medicated Original Strength Body Powder, typically contains menthol (0.15%) and zinc oxide as active ingredients. Menthol serves as a topical analgesic and anti-itch agent by stimulating cold-sensitive receptors in the skin to provide a cooling sensation that distracts from pain and pruritus. Zinc oxide acts as a skin protectant and astringent, providing a physical barrier and helping to relieve minor skin irritations. The product line is used for the temporary relief of pain and itching associated with minor cuts, sunburn, insect bites, scrapes, and minor burns, while also offering moisture and odor control. The brand is produced by Chattem, a subsidiary of Sanofi.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gold Bond.